p.trevino

TL2 · Ilorin

Contributes reviews on supplier material. Based in Ilorin.

Joined 12 May 2025 · last posted 13d

80 posts, newest first. Showing up to 150.

Journal club: what we got wrong in an earlier session Replied, post #86 · Evidence › Journal club · 15 Jul 2026 · 29 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions.
How shortages have affected compounding permissions Replied, post #13 · Access › Shortages · 3 Jul 2026 · 1 like Two sentences on shortages and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is inferred…
Immortal time bias in a claims-database study — one year on Replied, post #5 · marked as the solution · Evidence › Study critique · 2 Jul 2026 · 20 likes A run-in period that excludes non-responders before randomisation changes what the trial is estimating. It is legitimate design and it must be stated in any summary.
Prescription requirements and telehealth models — a second dataset Replied, post #88 · Sourcing › Regulatory · 2 Jul 2026 · 0 likes The version of Prescription requirements and telehealth models that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had…
What a certificate commits its issuer to — one year on Replied, post #95 · Analytics › COA interpretation · 24 Jun 2026 · 1 like Post #93 describes the usual case. This is about the unusual one. Peptide content and chromatographic purity are separate determinations and a certificate that reports…
Naming conventions for research peptides and the confusion they cause Replied, post #12 · Compounds › Other compounds · 7 Jun 2026 · 11 likes Post #9 is the version of this I will quote in future. One addition. Adding the boring version of naming conventions for research peptides, because the interesting…
Reading a trial's population section before its results Replied, post #88 · Evidence › Trials · 4 Jun 2026 · 2 likes Funding and trial conduct should be stated and are a weak predictor of anything on their own. Design quality is the stronger signal and it is checkable. Correct me on…
An appeal that succeeded, with the letter structure — the long version Replied, post #48 · Access › Insurance & coverage · 3 Jun 2026 · 19 likes On appeal the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
Micro-titration: a disputed topic, argued properly Replied, post #82 · Practice › Dosing & titration · 31 May 2026 · 16 likes Post #79 is right about the mechanism and I think understates the practical bit. Reframing micro-titration slightly, because I think the disagreement is about the…
Reading a trial's population section before its results Replied, post #63 · Evidence › Trials · 28 May 2026 · 3 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
Revisiting: Primary endpoint hierarchies and why order matters Replied, post #26 · Evidence › Trials · 12 May 2026 · 0 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #22 · Pharmacology › Formulation chemistry · 11 May 2026 · 0 likes Post #18 put the caveat in the right place and I want to underline it. Isotonicity: an isotonic solution has the same osmotic pressure as blood. Non-isotonic solutions…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #40 · Compounds › Tirzepatide · 11 May 2026 · 23 likes Having read the whole Tirzepatide and nausea thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a…
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #37 · Practice › Interactions · 3 May 2026 · 22 likes Fair, and the limits you put on it are the part I will remember.
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #54 · Devices › Syringes & needles · 23 Apr 2026 · 2 likes This follows post #51 rather than contradicting it. An observation about 0.3 ml versus 0.5 ml that I cannot explain and am posting anyway, on the principle that…
Coming back to: Time to steady state after a dose increase Replied, post #38 · Pharmacology › Pharmacokinetics · 23 Apr 2026 · 6 likes Understood. Thank you for being specific about the limits of it.
Micro-titration: a disputed topic, argued properly Replied, post #61 · Practice › Dosing & titration · 17 Apr 2026 · 8 likes Where I part company with post #57, and it is a narrow parting. A missed dose in a weekly schedule is not a trough to chase. With a week-long half-life you are…
A 40-week log with the measurement method stated — what changed since Started this topic · Outcomes › Progress reports · 10 Apr 2026 · 10 likes A 40-week log with the measurement method stated — what changed since Writing it up because I had to work it out twice and would rather nobody else did. Posting a small…
Second pass at: Identical chromatograms across two different lots Replied, post #70 · Sourcing › Red flags · 16 Mar 2026 · 0 likes Identical chromatograms came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #70 · Compounds › Semaglutide · 22 Feb 2026 · 0 likes Taking post #67 at face value and following it one step further. Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the…
Dead volume across syringe and needle combinations Replied, post #66 · Devices › Syringes & needles · 4 Feb 2026 · 5 likes Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are courser. For subcutaneous injection, 27-30G is typical. Finer needles take…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #79 · Access › Pricing · 3 Feb 2026 · 15 likes Building on post #77 rather than restating it. Where somebody posts a comparison, the useful version states the date, the region and what was included. It is the sort…
When a dose reduction is the correct response to a side effect — a second dataset Replied, post #5 · Practice › Dosing & titration · 20 Jan 2026 · 21 likes Answering the question the opening post raises rather than the one it answers. Dose equivalence between different incretin analogues is a weak concept. The molecules…
MHRA statements, read directly Replied, post #69 · Regional › UK & Ireland · 16 Jan 2026 · 21 likes Members outside these two jurisdictions reading this thread should note that none of it transfers, including the parts that sound general. I am describing what is,…
Adolescents: a distinct evidence base — one year on Replied, post #53 · Clinical › Special populations · 12 Jan 2026 · 26 likes Genetic and ancestry-related differences in response are asked about regularly and the published evidence is thin enough that the honest answer is short.
Personal import allowances, compared — a second dataset Replied, post #49 · Access › International · 9 Jan 2026 · 0 likes Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago. Speaking for…
Tracking that stops updating and then resumes Replied, post #62 · Sourcing › Logistics · 31 Dec 2025 · 4 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing.
[2026 update] Publication patterns in the BPC-157 literature, examined Replied, post #2 · Compounds › Repair & healing peptides · 25 Dec 2025 · 0 likes The strongest argument against my own position on Publication patterns, stated as well as I can state it, since nobody else has yet.
[2026 update] What a good consultation looks like from the other side Replied, post #8 · Clinical › Prescriber conversations · 20 Dec 2025 · 0 likes Confirming post #7 from a second method, which matters more than confirming it from a second person. Good consultation has a well-known answer and a correct answer, and…
Temperature loggers worth the money — the long version Replied, post #87 · Devices › Cold chain · 5 Dec 2025 · 8 likes The strongest argument against my own position on Temperature loggers worth the money, stated as well as I can state it, since nobody else has yet.
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #22 · Outcomes › Body composition · 2 Dec 2025 · 21 likes Sensible. I would want the same detail before I acted on it either.
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #59 · Clinical › Special populations · 29 Nov 2025 · 0 likes Confirming post #57 from a second method, which matters more than confirming it from a second person. I would call the community position on Older adults likely rather…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #56 · Compounds › Semaglutide · 27 Nov 2025 · 18 likes Post #54 put the caveat in the right place and I want to underline it. The failure mode on semaglutide half-life is boring rather than dramatic. It is almost always the…
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #72 · Compounds › Tirzepatide · 22 Oct 2025 · 0 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
Follow-up: The decimal-point error, and the habit that catches it Replied, post #68 · Practice › Reconstitution · 28 Sep 2025 · 3 likes Answering the question post #66 raises rather than the one it answers. Adding a reference point for decimal-point error. Mine is a single case, collected without…
A preprint whose numbers changed substantially at publication Replied, post #56 · Evidence › Preprints · 17 Sep 2025 · 9 likes Where a preprint's numbers are the basis of a claim being repeated here, someone should check whether the published version exists yet. That check is nearly always…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #32 · Data & Tools › Datasets · 7 Sep 2025 · 9 likes I read post #28 twice before replying, because I had assumed the opposite. I have three months of notes on Aggregated purity results across four and the honest summary…
EU-wide position versus national implementation Replied, post #27 · Regional › European Union · 20 Aug 2025 · 0 likes Answering the question post #25 raises rather than the one it answers. A request rather than an answer: could whoever has the primary source for eu-wide position versus…
About the European Union category Replied, post #4 · Regional › European Union · 17 Aug 2025 · 17 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
An emergency department visit, described afterwards Replied, post #53 · Safety › Adverse events · 12 Aug 2025 · 8 likes The published trial rates come from supervised populations on defined schedules and are not comparable to rates derived from who chooses to post. Small point, but it is…
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #43 · Compounds › Retatrutide · 10 Aug 2025 · 3 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
Travel coolers and how long they really hold Replied, post #66 · Devices › Cold chain · 6 Aug 2025 · 17 likes Answering the question post #63 raises rather than the one it answers. Trying to state the travel coolers position in a way that someone who disagrees would recognise…
A request that was declined, and the reasoning — a second dataset Replied, post #3 · Documentation › Wiki requests · 4 Aug 2025 · 0 likes Good question, well framed, and I would like to see it answered properly.
How to research a compound with no human data without deceiving yourself Replied, post #88 · Compounds › Other compounds · 3 Aug 2025 · 0 likes Post #84 put the caveat in the right place and I want to underline it. I think the research a compound question is answerable and has not been answered, which is a more…
How to research a compound with no human data without deceiving yourself Replied, post #63 · Compounds › Other compounds · 2 Aug 2025 · 1 like Confirming post #60 from a second method, which matters more than confirming it from a second person. Anything in this subcategory with a published trial behind it…
Power cut for eleven hours: how I assessed it afterwards Replied, post #8 · Practice › Storage & stability · 28 Jul 2025 · 8 likes Reading back through the power cut for eleven hours threads from last year, the same three questions come up every time and only one of them has ever been answered…
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #44 · Compounds › Cagrilintide & amylin analogues · 10 Jul 2025 · 22 likes Practical experience of Nausea profile of amylin analogues, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are…
"Greater than or equal to 99%" as a specification rather than a result Replied, post #4 · Analytics › COA interpretation · 6 Jul 2025 · 10 likes The opening post is right about the mechanism and I think understates the practical bit. A chromatogram supplied as a small image is legible for peak shape and not for…
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #81 · Compounds › Tirzepatide · 3 Jul 2025 · 4 likes On purity: the trailing-edge features people report on tirzepatide chromatograms are frequently deamidation products, which elute close to the main peak and are easy to…
Antibiotics and a course of something with delayed emptying Replied, post #71 · Practice › Interactions · 22 Jun 2025 · 17 likes Taking post #70 at face value and following it one step further. Reporting rather than recommending, on antibiotics. What happened is above. Whether it should have is a…
Distinguishing a deletion sequence by mass alone — the long version Replied, post #27 · Analytics › Mass spectrometry · 16 Jun 2025 · 19 likes A mass match establishes that the measured mass is consistent with the proposed composition. It does not establish purity, sequence order, or the absence of an isomer,…
Coming back to: Why quantitation is the hard part, not detection Replied, post #26 · Analytics › Home & field testing · 13 Jun 2025 · 0 likes That reframing is the whole thing. The facts I already had.
Meeting a protein target on a suppressed appetite Replied, post #3 · Nutrition & Training › Protein & intake · 31 May 2025 · 0 likes Where intake has fallen a long way, protein is usually the first thing to fall because it is the least appealing macronutrient when appetite is reduced.
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #62 · Compounds › Tirzepatide · 29 May 2025 · 32 likes One caution on GIP component of tirzepatide: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is…
Washout: how long is long enough, and for what purpose Replied, post #29 · Pharmacology › Pharmacokinetics · 24 May 2025 · 16 likes Worth separating two things that post #27 runs together. A pharmacokinetic model fitted to trial data describes the population studied. Applying it to somebody outside…
Half-life, steady state, and accumulation worked through Replied, post #4 · Pharmacology › Pharmacokinetics · 19 May 2025 · 0 likes Adding the measurement that the opening post says would settle it. Agreed on half-life, with one qualification that I think matters. The reasoning holds for the case as…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #99 · Sourcing › Independent verification · 15 May 2025 · 24 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #79 · Practice › Interactions · 9 May 2025 · 0 likes Anticoagulant questions come up regularly and are the clearest case for professional advice rather than discussion, because the consequence of being wrong is not…
DXA precision and the least significant change for lean mass — the long version Replied, post #2 · Outcomes › Body composition · 3 May 2025 · 0 likes The reason DXA precision is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is silent.
Journal club: SURMOUNT-1, read without the press release Replied, post #105 · Evidence › Journal club · 27 Apr 2025 · 1 like SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
Reading order for a first week here, and what to skip until later Replied, post #92 · Start Here › Welcome · 20 Apr 2025 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Adjudicated events and why the definition matters — the long version Replied, post #107 · Evidence › Trials · 19 Apr 2025 · 17 likes The version of Adjudicated events that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #51 · Sourcing › Vendor reports · 3 Apr 2025 · 26 likes Picking up post #50: that is the part I would want checked first. The cost of a submission is worth stating. It is the main reason people do not do this and knowing the…
Why cagrilintide alone is discussed so much less than in combination Replied, post #71 · Compounds › Cagrilintide & amylin analogues · 31 Mar 2025 · 1 like Adding the measurement that post #68 says would settle it. The claim about cagrilintide alone upthread is stronger than its source supports. I have read the source. The…
Review cadence: how often is a page actually re-checked? Replied, post #2 · Documentation › Doc review · 28 Mar 2025 · 13 likes Coming back to the opening post, because the follow-up matters more than the original answer. Where a review raises something the author disagrees with, recording the…
Follow-up: Journal club: the retatrutide phase 2 obesity paper Replied, post #6 · Evidence › Journal club · 19 Mar 2025 · 1 like Post #4 put the caveat in the right place and I want to underline it. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for…
Counter-ion form: the field almost nobody reports — one year on Replied, post #83 · Analytics › COA interpretation · 15 Mar 2025 · 31 likes Counter-ion form belongs on the document and almost never is. Acetate and trifluoroacetate salts of the same peptide contain different amounts of peptide per milligram.…
Reading an MS report that only gives you a single number Replied, post #13 · Analytics › Mass spectrometry · 18 Feb 2025 · 0 likes Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal. Report whether desalting was used, because it can affect the…
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #98 · Compounds › Semaglutide · 2 Feb 2025 · 22 likes Semaglutide half-life was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
Specification in the result column: why that is a meaningful error — the long version Replied, post #8 · Analytics › COA interpretation · 14 Jan 2025 · 4 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
Gallbladder disease risk with rapid weight loss Replied, post #54 · Clinical › Comorbidities · 7 Jan 2025 · 0 likes Picking up post #53: that is the part I would want checked first. Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The…
A page that has drifted out of date and needs a maintainer Replied, post #44 · Documentation › Wiki requests · 26 Dec 2024 · 11 likes Helpful, and easy to find again, which is half of what a good reply is.
What we do not know about retatrutide, listed explicitly Replied, post #28 · Compounds › Retatrutide · 21 Dec 2024 · 0 likes Adding the measurement that post #26 says would settle it. Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not…
Building a sensible monitoring schedule with your prescriber Replied, post #53 · Clinical › Bloodwork · 20 Dec 2024 · 0 likes A trend needs at least three points to be a trend. Two points are a line and a line through noise is still a line. That is the shape of it. The detail is where I would…
Checking someone else's arithmetic: a worked example thread Replied, post #3 · Practice › Reconstitution · 20 Nov 2024 · 13 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #29 · Sourcing › Regulatory · 15 Nov 2024 · 17 likes Two people in this thread mean different things by Research-use-only labelling and are disagreeing about the definition while believing they are disagreeing about the…
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #51 · Compounds › Repair & healing peptides · 14 Nov 2024 · 16 likes Reading a preclinical wound-healing model: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that…
Revisiting: Moderation log format change Replied, post #6 · Meta › Announcements · 24 Oct 2024 · 16 likes A request rather than an answer: could whoever has the primary source for Moderation log format change post it? I have seen the claim three times this month and each…
Correlation in a self-tracked dataset: what it can support Replied, post #53 · Research Methods › Statistics · 22 Aug 2024 · 8 likes Picking up post #51: that is the part I would want checked first. Percentages of small denominators should be reported with the denominator. Two out of three is not…
Cold packs, phase-change material, and what survives ten days Replied, post #130 · Sourcing › Logistics · 21 Jul 2024 · 0 likes Quietly grateful for the plain phrasing. Not every thread gets that.